Safety and Efficacy of Fluticasone Propionate/Salmeterol Hydrofluoroalkane 134a Metered-Dose-Inhaler Compared with Fluticasone Propionate/Salmeterol Diskus in Patients with Chronic...

by Koser, Andras, Westerman, Jan, Sharma, Sanjay, Emmett, Amanda, Crater, Glenn D
Published 2010

Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk

by Covelli, Henry, Pek, Bonavuth, Schenkenberger, Isabelle, Scott-Wilson, Catherine, Emmett, Amanda, Crim, Courtney
Published in Int J Chron Obstruct Pulmon Dis (2015)

Disease severity and symptoms among patients receiving monotherapy for COPD

by Dransfield, Mark T, Bailey, William, Crater, Glenn, Emmett, Amanda, O'Dell, Dianne M, Yawn, Barbara
Published in Prim Care Respir J (2011)

A Patient-Centered Walking Program for COPD

by Bender, Bruce G., Depew, Ann, Emmett, Amanda, Goelz, Kelly, Make, Barry, Sharma, Sanjay, Underwood, Jennifer, Stempel, David
Published in Chronic Obstr Pulm Dis (2016)

A randomized, controlled, repeat-dose study of batefenterol/fluticasone furoate compared with placebo in the treatment of COPD

by Crim, Courtney, Gotfried, Mark, Spangenthal, Selwyn, Watkins, Michael, Emmett, Amanda, Crawford, Catriona, Baidoo, Charlotte, Castro-Santamaria, Ramiro
Published in BMC Pulm Med (2020)

Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation

by Ohar, Jill A, Crater, Glenn D, Emmett, Amanda, Ferro, Thomas J, Morris, Andrea N, Raphiou, Ibrahim, Sriram, Peruvemba S, Dransfield, Mark T
Published 2014

Safety of Patients with Hepatitis C Virus Treated with Glecaprevir/Pibrentasvir from Clinical Trials and Real-World Cohorts

by Forns, Xavier, Feld, Jordan J., Dylla, Douglas E., Pol, Stanislas, Chayama, Kazuaki, Hou, Jinlin, Heo, Jeong, Lampertico, Pietro, Brown, Ashley, Bondin, Mark, Tatsch, Fernando, Burroughs, Margaret, Marcinak, John, Zhang, Zhenzhen, Emmett, Amanda, Gordon, Stuart C., Jacobson, Ira M.
Published in Adv Ther (2021)